Evidence map›Paper›PMID 36921206›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2023

Leptospirosis during the COVID-19 pandemic: a case report.

Mehmet Emir Arman, Mustafa Yavuz, Deniz Cekic, Kubilay Issever, Ahmed Cihad Genc, Selcuk Yaylacı

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mehmet Emir ArmanSakarya University, Training and Research Hospital, Department of Internal Medicine, Adapazari, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-4045-4969
Mustafa YavuzSakarya University, Training and Research Hospital, Department of Internal Medicine, Adapazari, Sakarya, Turkey.ORCID http://orcid.org/0000-0001-6270-1361
Deniz CekicSakarya University, Training and Research Hospital, Department of Internal Medicine, Adapazari, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-7114-9334
Kubilay IsseverGiresun University, Faculty of Medicine, Department of Internal Medicine, Giresun, Turkey.ORCID http://orcid.org/0000-0002-1376-1488
Ahmed Cihad GencSakarya University, Training and Research Hospital, Department of Internal Medicine, Adapazari, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-7725-707X
Selcuk YaylacıSakarya University, Training and Research Hospital, Department of Internal Medicine, Adapazari, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-6768-7973
Sakarya University · TRGiresun University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since SARS-CoV-2 disease (COVID-19) has been labeled as a pandemic, it took the spotlight in the differential diagnosis for patients presenting with acute respiratory and systemic symptoms. Leptospirosis is one of the most common zoonoses in the world, yet it is mainly a disease of differential diagnosis for places that do not have it as an endemic. Due to the high burden of COVID-19 on the healthcare field, patients suffering from other infections may have been inadvertently neglected. COVID-19 infection can mimic other infectious diseases and can confuse physicians in their search for a confirmatory diagnosis. Nonetheless, it is very crucial to broaden the differential diagnosis and keep diseases like leptospirosis within the differential diagnosis despite its rarity, especially in patients presenting with unexplained systemic infectious symptoms. This is a unique case of a patient who presented with dyspnea, jaundice and change in urine color who was suspected to be COVID-19 positive. After a detailed investigation, the patient was diagnosed with leptospirosis instead of COVID-19 and was treated with plasmapheresis and antibiotics accordingly.

Indexed as

COVID-19LeptospirosisAnimalsHumansPandemicsSARS-CoV-2Zoonoses

Identifiers

PMID36921206
PMCPMC10013484
OpenAlexW4324265044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.